State Street
WHWK

State Street’s Whitehawk Therapeutics WHWK Stock Holding History

State Street’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.77M Buy
386,982
+226,600
+141% +$943K ﹤0.01% 3369
2026
Q1 		$553K Buy
160,382
+14,845
+10% +$46.5K ﹤0.01% 3629
2025
Q4 		$352K Buy
145,537
+76,800
+112% +$176K ﹤0.01% 3772
2025
Q3 		$131K Hold
68,737
– – ﹤0.01% 4004
2025
Q2 		$129K Hold
68,737
– – ﹤0.01% 3930
2025
Q1 		$122K Hold
68,737
– – ﹤0.01% 3927
2024
Q4 		$217K Hold
68,737
– – ﹤0.01% 3834
2024
Q3 		$142K Hold
68,737
– – ﹤0.01% 3903
2024
Q2 		$100K Sell
68,737
-306,410
-82% -$568K ﹤0.01% 4014
2024
Q1 		$878K Buy
375,147
+60,238
+19% +$116K ﹤0.01% 3505
2023
Q4 		$636K Buy
314,909
+18,540
+6% +$77.8K ﹤0.01% 3588
2023
Q3 		$1.43M Sell
296,369
-1,654
-0.6% -$9.62K ﹤0.01% 3439
2023
Q2 		$2.04M Buy
298,023
+31,678
+12% +$246K ﹤0.01% 3407
2023
Q1 		$1.93M Buy
266,345
+301
+0.1% +$3.22K ﹤0.01% 3353
2022
Q4 		$3.41M Buy
266,044
+15,984
+6% +$209K ﹤0.01% 3207
2022
Q3 		$3.53M Sell
250,060
-285,554
-53% -$3.75M ﹤0.01% 3225
2022
Q2 		$6.6M Buy
535,614
+36
+0% +$535 ﹤0.01% 2956
2022
Q1 		$9.09M Buy
535,578
+224,178
+72% +$4.3M ﹤0.01% 2874
2021
Q4 		$7.52M Buy
+311,400
New +$7.82M ﹤0.01% 3055
2021
Q3 		– Sell
-8,523
Closed -$216K – 4710
2021
Q2 		$216K Buy
+8,523
New +$195K ﹤0.01% 4190

Other funds holding WHWK

YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street's WHWK Position: Q2 2026 in Review

State Street increased its Whitehawk Therapeutics (WHWK) stake by 141% in Q2 2026, buying an estimated $943K and bringing the position to 386,982 shares worth $1.77M. The position accounts for ﹤0.01% of the portfolio, ranked #3369.

State Street first reported a position in WHWK in Q2 2021 and has held it in 20 quarters since. The position peaked at $9.09M in Q1 2022. 77 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

  • State Street held 386,982 shares of Whitehawk Therapeutics worth $1.77M as of Q2 2026.
  • State Street bought 226,600 Whitehawk Therapeutics shares in Q2 2026, an estimated $943K.
  • Whitehawk Therapeutics made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3369 holding.
  • State Street first reported a position in Whitehawk Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • State Street's Whitehawk Therapeutics position peaked at $9.09M in Q1 2022.
  • 77 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.